Characterization of varicella-zoster virus-encoded ORFO gene-Comparison of parental and vaccine strains

被引:29
作者
Koshizuka, Tetsuo [1 ]
Ota, Megumi [1 ,2 ]
Yamanishi, Koichi [1 ]
Mori, Yasuko [1 ,2 ]
机构
[1] Natl Inst Biomed Innovat, Lab Virol & Vaccinol, Div Biomed Res, Osaka 5670085, Japan
[2] Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 657, Japan
基金
日本学术振兴会;
关键词
VZV; ORFO; vOka; pOka; Attenuation; Vaccine; BACTERIAL ARTIFICIAL CHROMOSOME; MEASLES-VIRUS; ESCHERICHIA-COLI; INFECTED-CELLS; MEMBRANE-PROTEINS; RECEPTOR CD46; SYSTEM; EFFICIENT; RECOMBINATION; ATTENUATION;
D O I
10.1016/j.virol.2010.06.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The varicella-zoster virus (VZV) Oka vaccine strain (vOka) differs from the parental strain (pOka) at several amino acid positions, but the mutations responsible for the attenuation of vOka have not been clearly defined. The ORFO of vOka carries some of the mutations. Although we found that the ORFO of both strains was incorporated into virus particles, the C-terminal region of vOka ORFO was presented on the virion surface and was N-glycosylated, suggesting that the mutation in vOka ORFO changes it into a novel envelope glycoprotein. In a mutant virus in which pOka ORFO was replaced by vOka ORFO, the molecular weight of ORFO was altered, but the plaque size was not. In addition, a pOka recombinant virus lacking the hydrophobic domain of ORFO grew equally well as the wild-type virus, indicating that the mutation in ORFO is not by itself sufficient for the attenuation of the vOka virus. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:280 / 288
页数:9
相关论文
共 36 条
  • [1] Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells
    Abendroth, A
    Lin, I
    Slobedman, B
    Ploegh, H
    Arvin, AM
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (10) : 4878 - 4888
  • [2] Varicella vaccine: Genesis, efficacy, and attenuation
    Arvin, AM
    [J]. VIROLOGY, 2001, 284 (02) : 153 - 158
  • [3] The tale of tail-anchored proteins: coming from the cytosol and looking for a membrane
    Borgese, N
    Colombo, S
    Pedrazzini, E
    [J]. JOURNAL OF CELL BIOLOGY, 2003, 161 (06) : 1013 - 1019
  • [4] Safety of varicella vaccine after licensure in the United States: Experience from reports to the vaccine adverse event reporting system, 1995-2005
    Chaves, Sandra S.
    Haber, Penina
    Walton, Kimp
    Wise, Robert P.
    Izurieta, Hector S.
    Schmid, D. Scott
    Seward, Jane F.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 : S170 - S177
  • [5] Cohen J.I., 2007, FIELDS VIROLOGY, V2, P2773
  • [6] THE HUMAN CD46 MOLECULE IS A RECEPTOR FOR MEASLES-VIRUS (EDMONSTON STRAIN)
    DORIG, RE
    MARCIL, A
    CHOPRA, A
    RICHARDSON, CD
    [J]. CELL, 1993, 75 (02) : 295 - 305
  • [7] Analysis of receptor (CD46, CD150) usage by measles virus
    Erlenhöfer, C
    Duprex, WP
    Rima, BK
    ter Meulen, V
    Schneider-Schaulies, J
    [J]. JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 1431 - 1436
  • [8] Gomi Y, 2000, J MED VIROL, V61, P497, DOI 10.1002/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO
  • [9] 2-2
  • [10] Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus
    Gomi, Y
    Sunamachi, H
    Mori, Y
    Nagaike, K
    Takahashi, M
    Yamanishi, K
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (22) : 11447 - 11459